Colistimethate
COLISTIMETHATE SODIUM
- Strength
- 150 mg/2mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Polymyxin-class Antibacterial
Fresenius Kabi USA, LLC
Not stocked by us — reference only
colistimethate sodium
Listed by Xellia Pharmaceuticals USA LLC
| Dosage form | Injection, Powder, For Solution |
|---|---|
| Route | Intramuscular, Intravenous |
| Drug class | Polymyxin-class Antibacterial |
| Approval route | ANDA — approved generic |
| NDC code | 70594-023 |
| FDA application | ANDA205356 |
| RxNorm concept | 1117522 |
| Package sizes listed | 1 |
| Marketed since | February 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
COLISTIMETHATE SODIUM
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Colistimethate Sodium
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Heritage Pharmaceuticals Inc. d/b/a Avet Pharma…
Not stocked by us — reference only
colistimethate
Par Health USA, LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.